Curis
CRIS
#11190
Rank
โ‚น0.15 B
Marketcap
โ‚น64.93
Share price
-5.38%
Change (1 day)
-51.88%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -โ‚น1,381

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น1,376. In 2025 the company made an earnings per share (EPS) of -โ‚น2,303 an increase over its 2024 EPS that were of -โ‚น13,600.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น1,381-40.04%
2025-โ‚น2,303-83.07%
2024-โ‚น13,600-22.15%
2023-โ‚น17,469-26.17%
2022-โ‚น23,66022.3%
2021-โ‚น19,346-25.37%
2020-โ‚น25,924-30.93%
2019-โ‚น37,531-2.02%
2018-โ‚น38,305
2016-โ‚น87,057-10%
2015-โ‚น96,730138.1%
2014-โ‚น40,62740%
2013-โ‚น29,019-25%
2012-โ‚น38,69266.67%
2011-โ‚น23,215

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น73.51-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น439.15-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น34.82-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น319.21-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น420.78-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น307.60-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚น332.75-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA